Jump to Main Content

Press Releases

ASH Selects Seven Fellows to Receive Research Training Award to Support Careers in Academic Hematology

(WASHINGTON, June 30, 2016) The American Society of Hematology (ASH) today announced the names of seven outstanding fellows selected to receive the 2016 ASH Research Training Award for Fellows (RTAF), a year-long program that aims to encourage careers in academic hematology by providing protected research time during training.

Each RTAF awardee will receive $55,000 to support a hematology research project throughout the program’s duration, from July 1, 2016, to June 30, 2017. The majority of the award money will support the recipient’s salary, with a percentage to be used for research supplies and ASH annual meeting attendance. Awards are targeted to two groups of researchers based on experience: a Junior Investigator award for second- and third-year fellows, and a Senior Investigator award for fourth- and fifth-year fellows.

“Fellows who conduct high-quality research during their training improve their chances of receiving an academic appointment and research funding to start their careers; however, it is often difficult to devote time to research,” said ASH President Charles S. Abrams, MD, of University of Pennsylvania. “By supporting protected time for scientific exploration, the RTAF award positions the next generation of physician-scientists for successful careers in hematology.”

The 2016 ASH Research Training Award for Fellow recipients and their research topics are:

Recipient Research Topics

Waitmann Aumann, MD
Duke University Hospital
Durham, NC

CRM1 dimerization: A novel mechanism in CALM-AF10leukemia

Shruti Chaturvedi, MBBS
Vanderbilt University
Nashville, TN

Alternate pathway of complement in adults with sickle cell disease and acute chest syndrome

Gordon Cohen, MD, MPH
The Johns Hopkins University
Baltimore, MD

Overcoming imatinib resistance in pediatric Philadelphia chromosome-positive acute lymphocytic leukemia

Anna Halpern, MD
University of Washington
Seattle, WA

Developing and testing models to predict intensive care unit (ICU) admission and mortality for adults with acute myeloid leukemia (AML)

Sakiko Suzuki, MD
University of Massachusetts
Worcester, MA

Novel therapy of leukemia through alternative splicing of MPL

Justin Taylor, MD
Memorial Sloan Kettering Cancer Center
New York, NY

Biological and mechanistic effects of XPO1alterations in hematopoietic malignancies

Amy Tang, MD
New York-Presbyterian Hospital
New York, NY

Transfusion-related iron overload and post-transplantation outcomes in a chemotherapy-based mouse model of allogeneic stem cell transplant

The American Society of Hematology (www.hematology.org) is the world’s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.

Sara Khalaf, American Society of Hematology
[email protected]; 202-552-4925